Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial(Ⅱ)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Children aged ≥4 years.~* Meeting the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Edition 5 (DSM-5) .~* Confirmed by the ADOS and/or ADI-R diagnostic tool.~* Informed consent.~Exclusion Criteria:~* Patients with metal implants .~* Patients with neurological diseases such as epilepsy .~* Patients requiring surgical treatment due to structural abnormalities indicated by brain MRI .~* Genetic or chromosomal abnormalities .~* Suffering from mental disorders (such as mood disorders, etc.)~* Suffering from serious heart disease .~* Hearing-impaired .~* Intracranial hypertension .~* Participating in other clinical trials.~* Participants who received other interventions within 4 weeks prior to enrollment.

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- rTMS Group (Type: EXPERIMENTAL): Participants will receive cTBS over the left primary motor cortext (M1) for 5 consecutive days. The detailed parameters as follows: 80% of RMT, 60 cycles of 10 bursts of three pulses at 50 Hz were delivered in 2-second trains (5 Hz) with no intertrain interval (i.e. triplet standard cTBS, 1800 pulses, 120s). Stimulation sessions were delivered hourly, 10 sessions were applied per day (18,000 pulses/day).

Based on this trial design, predict the completion outcome and termination type (if applicable).